Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Roche-Phase-III-Efficacy-Results-of-Investigational-Medicine-OCREVUS-Ocrelizumab-Reinforced-b-23050699/?utm_source=whatsapp&utm_medium=social&utm_campaign=share